Login / Signup

Models of Congenital Adrenal Hyperplasia for Gene Therapies Testing.

Olga GlazovaAsya BastrichAndrei A DeviatkinNikita OnyanovSamira KaziakhmedovaLiudmila ShevkovaNawar SakrDaria PetrovaMaria V VorontsovaPavel Y Volchkov
Published in: International journal of molecular sciences (2023)
The adrenal glands are important endocrine organs that play a major role in the stress response. Some adrenal glands abnormalities are treated with hormone replacement therapy, which does not address physiological requirements. Modern technologies make it possible to develop gene therapy drugs that can completely cure diseases caused by mutations in specific genes. Congenital adrenal hyperplasia (CAH) is an example of such a potentially treatable monogenic disease. CAH is an autosomal recessive inherited disease with an overall incidence of 1:9500-1:20,000 newborns. To date, there are several promising drugs for CAH gene therapy. At the same time, it remains unclear how new approaches can be tested, as there are no models for this disease. The present review focuses on modern models for inherited adrenal gland insufficiency and their detailed characterization. In addition, the advantages and disadvantages of various pathological models are discussed, and ways of further development are suggested.
Keyphrases
  • gene therapy
  • replacement therapy
  • genome wide
  • pregnant women
  • gene expression
  • dna methylation
  • intellectual disability
  • preterm infants
  • genome wide identification
  • cord blood
  • preterm birth